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MouseTIF1β is an essential mammalian transcriptional corepressor. It interacts with the heterochromatin proteins
HP1 through a highly conserved motif, the HP1box, and we have previously shown that this interaction is
essential for the differentiation of F9 cells to occur. Here we address the in vivo functions of the TIF1β–HP1
interaction, by generating mice in which the TIF1β HP1box is mutated, leading to the loss of TIF1β interaction
with HP1. The effects of the mutation were monitored in two instances, where TIF1β is known to play key
roles: early embryonic development and spermatogenesis. We ﬁnd that mutating the HP1box of TIF1β
disrupts embryonic development soon after gastrulation. This effect is likely caused by the misexpression of
TIF1β targets that regulate mitotic progression and pluripotency. In contrast, in Sertoli cells, we found that the
absence of TIF1β but not its mutation in the HP1box leads to a clear defect of spermatogenesis characterized
by a failure of spermatid release and a testicular degeneration. These data show that the interaction between
TIF1β and HP1 is essential for some but not all TIF1β functions in vivo. Furthermore, we observed that TIF1β is
dispersed through the nucleoplasm of E7.0 embryos, whereas it is mainly associated with pericentromeric
heterochromatin of E8.5 embryos and of Sertoli cells, an association that is lost upon TIF1β HP1box mutation.
Altogether, these data provide strong evidence that nuclear organization plays key roles during early
embryonic development.ologie Moléculaire et Cellulaire
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The precise control of gene expression, cellular proliferation and
differentiation are essential for organism to ensure their integrity and
survival. During development, cell fate decisions are taken and tissue-
speciﬁc gene expression patterns have to be established and maintained.
The expression of pluripotency genes shuts down, the relevant tissue-
speciﬁc genes become expressed, and the genes characteristic of other
differentiation pathways become stably repressed (Mohn and Schübeler,
2009). There are increasing evidence that the structure of the chromatin
and the organization of the nucleus play key roles in these events (for
review Farnham, 2009; Takizawa et al., 2008). Of particular interest,
heterochromatin, a sub-nuclear compartment long thought as an inertstorage site for useless genetic information appears to be involved in
several regulatory processes within the nucleus. However how these
different levels of regulation are linked in vivo is still poorly understood.
One of the major components of heterochromatin is the hetero-
chromatin protein 1 (HP1). HP1 proteins are highly conserved proteins
found in organisms ranging from ﬁssion yeast to human; they play a
crucial role in heterochromatin formation and contribute to the
regulation of gene expression (Hiragami and Festenstein, 2005;Hediger
and Gasser, 2006; Kwon and Workman, 2008). Mice and humans have
three HP1 isotypes (α, -β, and -γ) which are not fully functionally
redundant despite high structural and biochemical similarities (Aucott
et al., 2008). All three proteins are comprised of an N-terminal
chromodomain (CD) connected by a hinge region to a C-terminal
chromoshadow domain (CSD). The CD speciﬁcally binds di- and
trimethylated H3K9, the histone fold domain of H3, and methylated
H1.4K26 (Bannister et al., 2001; Lachner et al., 2001;Nielsen et al., 2001;
Daujat et al., 2005). The CSD is involved in self-association and also
serves as a docking site for a variety of nuclear proteins implicated in
transcriptional regulation, chromatin modiﬁcation, replication, DNA
Table 1
Genotype analysis of TIF1HP1box/+ intercross progeny.
Stage Genotype Total
+/+ HP1box/+ HP1box/HP1box
Newborn 47 57 0 104
E 12.5 5 6 0 11
E 11.5 10 20 5** (14%) 35
E 10.5 11 17 7** (20%) 35
E 9.5 10 28 13* (25%) 51
E 8.5 24 60 27* (24%) 111
*Embryos are growth retarded.
**Embryos are dead and eventually partially resorbed.
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et al., 2000; Kwon and Workman, 2008; Dinant and Luijsterburg, 2009
and references therein). Thus, HP1 can be thought as bridging proteins,
connectinghistones through interactionswith theCD, to diversenuclear
proteins, through interactions via their CSD. However, the mechanisms
by which HP1 interactions regulate chromatin structure, gene expres-
sion, and ultimately cell fate are poorly understood.
Sequence comparison of a large number of HP1 partners
identiﬁed the presence of a conserved PxVxL pentapeptide motif
called HP1box, which is necessary and sufﬁcient for their
interaction with HP1 (Le Douarin et al., 1996; Murzina et al.,
1999; Smothers and Henikoff, 2000). Speciﬁc amino acid changes
within the HP1box have been identiﬁed that selectively disrupt
interaction with HP1, thus providing tools to investigate the
physiological relevance of this interaction (Thiru et al., 2004). For
instance speciﬁc disruption of the PxVxL motif has revealed that
the interaction between HP1 and the histone chaperone CAF1 is
essential for the speciﬁc targeting of CAF1 to replication foci
within heterochromatin, and for appropriate replication of this
condensed chromatin structure (Quivy et al., 2008).
Amongotherwell-establishedHP1-bindingmotif containing partners,
the transcriptional intermediary factor 1 (TIF1) β (also named KAP-1 or
TRIM28) exerts cellular functions essential for gastrulation and sper-
matogenesis in mice (Cammas et al., 2000; Weber et al., 2002). Initially
identiﬁed through its ability to interact with the three mammalian HP1s
(Le Douarin et al., 1996), TIF1β is also known as the essential corepressor
for the large family of Krüppel-associated box (KRAB) zinc ﬁnger DNA
binding proteins (Friedman et al., 1996; Abrink et al., 2001). Structurally,
TIF1β consists of an N-terminal RING-B boxes-coiled coil (RBCC or
tripartite)motif and a C-terminal PHD ﬁnger-bromodomain unit (see Fig.
S1).Mechanistically, it displays characteristics of amolecular scaffold that
coordinates the recruitment of histone modifying and remodeling
activities required for the deposition of HP1, which in turn contributes
to thestable formationofhighly localizedcondensedchromatin structures
that associate with pericentromeric heterochromatin to yield heritable
gene silencing (Ayyanathan et al., 2003; Sripathy et al., 2006; Riclet et al.,
2009). TIF1β has also recently been shown to be essential for silencing of
retrotransposons through interaction with both KRAB-ZFPs and HP1
(Wolf and Goff, 2007, 2009; Wolf et al., 2008; Matsui et al., 2010; Rowe
et al., 2010).
In mouse embryonic carcinoma F9 cells, the TIF1β HP1box is
instrumental to the TIF1β euchromatin to heterochromatin relocation
that accompanies primitive endodermal differentiation (Cammas
et al., 2002) as well as to progression through terminal differentiation
(Cammas et al., 2004). Although these data indicate that the
heterochromatic and euchromatic compartments can communicate
through HP1-directed nuclear compartmentalization of TIF1β, the
actual role of TIF1β–HP1 interaction in TIF1β physiological and
developmental functions still remains to be determined.
In the present study, we have assessed the functional relevance
of the interaction between TIF1β and HP1 by genetically disrupting
the TIF1β HP1box either in the whole mouse or speciﬁcally in Sertoli
cells. We demonstrate that the integrity of the TIF1β HP1box is
essential for early post-gastrulation development, whereas it is
dispensable for TIF1β speciﬁc functions within Sertoli cells during
spermatogenesis. Altogether our data suggest that the relocation of
TIF1β from euchromatin to heterochromatin rather than its
association per se to heterochromatin is important for TIF1β
functions during differentiation.
Results
The TIF1β HP1box is essential for early post-gastrulation development
ES cells targeted by homologous recombination were used to
generate mice carrying alleles of TIF1β mutated in the HP1boxencoding sequence, designated hereafter, at the homozygous state, as
TIF1βHP1box mutants (Fig. S1; Cammas et al., 2004). TIF1βHP1box/+
heterozygous mice, which were viable and fertile, were intercrossed.
Mendelian ratios of wild-type (WT), TIF1βHP1box/+ and TIF1βHP1box
embryoswere observed up to embryonic day (E) 8.5 and 9.5 (Table 1).
By E10.5, however, there were fewer TIF1βHP1box homozygous
mutants than predicted and all were dead (Table 1). At day E11.5,
the homozygous mutant tissues that could be genotyped were
necrotic. No TIF1βHP1box mutant was ever recovered at, or after
E12.5 (Table 1 and data not shown). Therefore, similar to the TIF1β
null mutation (Cammas et al., 2000), the TIF1βHP1box knock-in (KI)
mutation causes recessive embryonic lethality.
Representative external and histological aspects of WT and
TIF1βHP1box mutants embryos collected at different times of
gestation are displayed in Fig. 1A(a and b) and B(a–i). At the
late gastrula stage (E7.0), TIF1βHP1box mutants were indistinguish-
able from WT embryos, as they all exhibited three germ layers and
normal extraembryonic structures (Fig. 1A(a–d)). Similar to WT
embryos, TIF1βHP1box mutants expressed the mesodermal marker
Brachyury (compare Fig. 1A, e and f). At E8.5, however, TIF1βHP1box
mutants were markedly retarded (Fig. 1B, a and b), while at E9.5
their body size, number of somites (10–12), and organs (Fig. 1B, d
and h) resembled those of E8.5 WT embryos (Fig. 1B, a and i).
Moreover, E8.5 and E9.5 TIF1βHP1box mutants constantly displayed
abnormal cranial neural tube closure and embryonic turning
(Fig. 1Bd). At E10.5, TIF1βHP1box mutants were all dead, as assessed
by the absence of heart beats (Fig. 1Bf and data not shown). Taken
together, these results demonstrate that the HP1-binding domain
of TIF1β is dispensable for mesoderm induction and gastrulation,
but required shortly thereafter for early organogenesis.The TIF1β HP1box is essential for cell cycle regulation during
development
Growth retardation can result from altered cell death and/or cell
proliferation. Apoptotic cell death, assessed by TUNEL assays, was not
different between E7.5 WT and TIF1βHP1box mutants (Fig. 2A) or
between E8.5WT and E9.5 TIF1βHP1boxmutants (data not shown). Cell
proliferation was assessed at E7.5 by BrdU incorporation and
detection of mitosis by immunostaining histological sections with
an antibody to phosphorylated histone H3. A small, but signiﬁcant,
1.3-fold decrease in the percentage of cells in S-phase was detected in
TIF1βHP1box mutants as compared to their WT littermates (Fig. 2B). In
contrast, the number of cells in M-phase was signiﬁcantly higher in
TIF1βHP1box mutants (Fig. 2C). In this respect, it is interesting to
mention that we recently found that replacement of TIF1β by a
TIF1βHP1box mutant protein in F9 cells increases expression of the
mitotic checkpoint Pttg1 (Pituitary Tumor-Transforming Gene 1). Pttg1
transcription was increased in both undifferentiated and in retinoic
acid-treated TIF1βHP1box/− F9 cells, as compared to TIF1β+/− cells
placed under identical culture conditions, and the amount of PTTG1,
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Fig. 2. Apoptosis and proliferation in TIF1βHP1boxmutants. (A) TUNEL-positive cells inWT (black bar) and TIF1βHP1box mutant (white bar) embryos. (B) Quantiﬁcation of proliferation
after BrdU immunoﬂuorescence analysis of E7.5 WT and TIF1βHP1box mutant embryos. (C) Quantiﬁcation of mitotic cells by immunostaining with anti-phosphorylated-histone H3
(PH3) antibody. The mean proportion (± SD) of positive cells was determined from sections of whole embryo and from three different embryos per genotype. Statistical signiﬁcance
was analyzed using Student's t tests (*, Pb0.05; **, Pb0.01). (D and E) RT-PCR analysis of Pttg1 using RNA isolated from (D) TIF1β+/− and TIF1βHP1box/− F9 cells and (E) from E7.5WT
and TIF1βHP1box littermates (n=6). Results are presented as expression relative to Hprt, with expression of Pttg1 arbitrarily set equal to one for the WT samples. Each column
represents the mean±SD of at least three independent experiments (*, Pb0.05; **, Pb0.005). (F) Western blot analysis of PTTG1 expression in TIF1β+/− and TIF1βHP1box/− F9 cells
synchronized in mitosis. Whole cell extracts (10 μg) from TIF1β+/− and TIF1βHP1box/− F9 cells treated with 0.12 μg/ml nocodazole for 24 h were resolved by SDS-PAGE and analyzed
by immunoblotting with the monoclonal anti-TIF1β antibody 1 TB3 (Nielsen et al., 1999). β-Actin served as loading control.
551M. Herzog et al. / Developmental Biology 350 (2011) 548–558measured by Western blotting, was increased in TIF1βHP1box/− cells
synchronized in M-phase as compared to TIF1β+/− F9 cells (Fig. 2D
and F and data not shown). These in vitro results encouraged us to
investigate Pttg1 expression in E7.5 TIF1βHP1box embryos. RT-PCR
analysis showed a statistically signiﬁcant 2.3-fold increase in the
expression level of Pttg1 in TIF1βHP1box mutants as compared to their
WT littermates (Fig. 2E). These data indicate that the TIF1β HP1box is
essential for accurate control of Pttg1 expression during embryonic
development and suggest that Pttg1 over-expression could account
for the abnormal cell cycle of TIF1βHP1box mutants. Because the cell
cycle regulator cyclin-dependent kinase inhibitor p21/CIP1/WAF1
(referred hereafter as p21) has already been proposed to be a TIF1β
target gene and could have relevance in the proliferation defect
observed in our mutant embryos, its expression was also veriﬁed at
E7.5. Semi-quantitative RT-PCR analysis shows that, although p21
expression was quite variable between embryos, there was a 3.1-fold
increased expression in mutant embryos as compared to their WT
counterparts (Fig. S2). Taken together, the above results indicate thatFig. 1. (A) TIF1βHP1boxmutants undergo gastrulation. (a,b) External aspect, (c,d) histological a
(WT) and TIF1βHP1box mutant littermates. Abbreviations: ce, cuboidal visceral endoderm; e
lines); ee, embryonic ectoderm; ep, ectoplacental cone; exe, extraembryonic ectoderm;
endoderm. Bar (in F): 560 μm (a, b), 50 μm (c–f). See also Fig. S1. (B) TIF1βHP1box mutation d
TIF1βHP1box mutant littermates at E8.5, E9.5 and E10.5, respectively. (g and h) Representat
sections of WT embryos at E8.5 are comparable to sections of mutant embryos at E9.5. A
diverticulum; hf, head fold; hl, hindlimb bud; me, mesencephalon; o, otocyst; ov, optic vesicl
(d). Bar (in I): 200 μm (a–bb), 900 μm (c–f), 110 μm (g–i).the integrity of the HP1box of TIF1β is required for proper cell cycle
progression during embryonic development.
The TIF1β HP1box is essential for controlling Nanog and Oct4 expression
TIF1β was recently shown to play an important role in the
pluripotency of ES cells (Hu et al., 2009). This led us to assess the
expression of Nanog and Oct4, which are both required for the
maintenance of stem cell pluripotency (reviewed by Chambers and
Tomlinson, 2009). We analyzed TIF1βHP1box mutant embryos at
E6.5 which are morphologically normal and in which Nanog and
Oct4 expression levels are high and functionally relevant for the
subsequent developmental steps (Chambers et al., 2003, 2007).
Quantitative RT-PCR analysis revealed that expression of Nanog
and Oct4 was decreased by 2.7- and 3.8-fold respectively, in
TIF1βHP1box mutants as compared to WT embryos indicating that
TIF1β interaction with HP1 is involved in the regulation of Oct4
and Nanog expression (Fig. 3A and B).nalysis and (e,f) in situ hybridization analysis of Brachyury expression of E7.0 wild-type
and ex, embryonic and extraembryonic portions of the conceptus (separated by black
m, mesoderm; p, proamniotic cavity; pe, parietal endoderm; se, squamous visceral
elays embryonic development by E8.5. (a,b), (c,d) and (e,f) External aspect of WT and
ive histological sections of E9.5 WT and TIF1βHP1box mutant embryos. (i) Histological
bbreviations: al, allantois; cc, coelomic cavity; ﬂ, forelimb bud; h, heart; hd, hepatic
e; pr, prosencephalon; so, somites; the arrow points to the failure of neural tube closure
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Fig. 3. Integrity of the TIF1β HP1box is required for appropriate embryonic expression
of Nanog and Oct4. RT-PCR analysis of (A) Nanog and (B) Oct4 expression using RNA
isolated from WT and TIF1βHP1box littermates (n=6) at E6.5 Results are presented as
expression relative to Hprt, with expression of Nanog and Oct4 arbitrarily set equal to
one for the WT samples. (*, Pb0.05; **, Pb0.005).
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development
As the early embryonic lethality of TIF1βHP1box mutants indicated an
indispensable function for the HP1-binding activity of TIF1β, we analyzed
the sub-nuclear localization of TIF1β by immunohistochemistry on
sections of E7.0 and E8.5 embryos and used a DAPI counterstain as a
marker of pericentromeric heterochromatin. TIF1β was expressed
throughout the embryonic tissues (Fig. 4A–D). Confocal microscopy
analysis of WT embryos at E7.0 showed that TIF1β was diffusely
distributed within the nucleoplasm in a majority of nuclei (Fig. 4B,
arrowhead),whereas at E8.5 it displayed a pericentromeric localization in
virtually all cells (Fig. 4D). Importantly, the association of TIF1β with
heterochromatinwas not observed in E8.5 TIF1βHP1boxmutants (compare
Fig. 4E and F with Fig. 4G and H). These results demonstrate that TIF1β
relocates from euchromatin to heterochromatin shortly after gastrulation
in an HP1box-dependent manner.
Todeterminewhether thedisruptionof the interactionbetweenTIF1β
and HP1 had consequences on HP1 localization and on heterochromatin
organization on its whole, we analyzed HP1α localization in WT and
TIF1βHP1box embryos. As shown on Fig. 5, HP1α was expressed at
equivalent levels and displays the same sub-nuclear localization in both
WT and TIF1βHP1box embryos. Altogether these results demonstrate that
the disruption of the interaction between TIF1β andHP1 speciﬁcally leads
to the exclusion of TIF1β from heterochromatin without any detectable
consequences on HP1 and heterochromatin organization.
Speciﬁc TIF1β gene targeting in Sertoli cells
Next, we investigated the role of TIF1β and its interactionwith HP1
in cells that were already committed to speciﬁc lineages. We decided
(i) to ablate TIF1β or (ii) to mutate the TIF1β HP1box in the testicular
Sertoli cells (SC) which act as supporting cells for the male germ cell
lineage.
To this end we made use of the Amh-Cre transgenic mouse line in
which the Cre recombinase expression is regulated by the anti-Müllerian
hormone promoter which is active only in SC (Amh-Cretg/0 line; Lécureuil
et al., 2002).Weproducedmice having TIF1β inactivated speciﬁcally in SC
(thereafter called TIF1βSc−/−) and mice with TIF1β HP1box mutated
speciﬁcally in SC (thereafter called TIF1βScHP1box/−; see Materials and
methods). The presence and the sub-nuclear distribution of TIF1β in SC
were analyzed in each aforementioned mouse line by confocal immuno-
ﬂuorescence microscopy. In 7-week-old males, SC are terminallydifferentiatedwith respect to cell polarity, G0 arrest and ability to support
the differentiation of functional spermatozoa. In testes of WT mice and
TIF1βSc+/− mutants, TIF1β was unevenly distributed with an intense
pericentromeric heterochromatin staining and a weak, diffuse, nucleo-
plasmic staining in all SC (Fig. 6A–C and G–I and Weber et al., 2002). As
expected TIF1β staining was absent speciﬁcally within Sertoli cells of
TIF1βSc−/− animals demonstrating the complete Sertoli cell-speciﬁc
inactivation of TIF1β (Fig. 6D–F and data not shown). In contrast, in SC
of TIF1βScHP1box/− testes, the TIF1βHP1box protein was distributed
throughout the nucleoplasm with the exclusion of the pericentromeric
heterochromatin (Fig. 6J–L). We also assessed the localization of HP α, β
and γ in the different genetic backgrounds. As in embryos, the levels of
expression and the sub-nuclear localization of the different HP1 isoforms
were very similar in TIF1βScL2/L2, TIF1βSc−/− and TIF1βScHP1box/− Sertoli
cells (Figs. S3–S5). These results indicate that the HP1-binding motif of
TIF1β is essential for its pericentromeric heterochromatin association in
SC, whereas it does not inﬂuence HP1 localization.
TIF1β but not its HP1box is essential for Sertoli cell functions
Mutant and control mice were analyzed for testis weight and testis to
bodyweight ratios at different ages after puberty [i.e. at 7 weeks (W7)and
12 months (M12) of age]. Body weights were similar in WT, TIF1βSc−/−,
TIF1βSc+/−andTIF1βScHP1box/−miceat all ages (datanot shown).However,
testis weights were reduced by 51% (Pb0.004) and 70% (P b 0.004),
respectively, in TIF1βSc−/−mutants at W7 and M12 as compared to their
WT littermates (Fig. S6; n=4 in each age group of WT or TIF1βSc−/−
mice). In marked contrast, there was no signiﬁcant difference in testis
weights between TIF1βScHP1box/− mutants and TIF1βSc+/− control mice
(Fig. S6; n=4 in each group). To investigate fertility, TIF1βSc−/− and WT
males were mated with WT C57/Bl6 females for 5 months. TIF1βSc−/−
males produced signiﬁcantly less litter per cage [3±2.18 (mean±SD,
n=9)], than WT males [7.75±1.71 (n=4; pb0,001)]. Moreover, the
mean number of newborns per litterwas signiﬁcantly reduced inmatings
involving TIF1βSc−/−males (3.3±2.6) as compared to those involvingWT
males (7.6±0.9; pb0.001). These results indicate that the TIF1βSer−/−
males are hypofertile.
Histological analysis of testes and epididymides was performed in
young (W7, n=10) as well as aged (M12, n=4) mice. All TIF1βSc−/−
mutants had normal SC as assessed by hematoxylin and eosin and
DAPI staining (Figs. 6 and 7 and data not shown) indicating that TIF1β
is not involved in themaintenance of the Sertoli cell morphology. Nine
out of the 10 TIF1βSer−/− mutants at W7 displayed an abnormal
testicular histology characterized by a decreased number of mature
spermatids (S16, compare Fig. 7A and D), that failed to become
aligned at the luminal side of the seminiferous tubules at stage VII of
the epithelial cycle (see Russell et al., 1990 for a description of the
epithelial stages). Moreover, mature spermatids were retained within
the seminiferous epithelium and therefore were still present at
epithelial stages IX and X, instead of being normally released at stages
VII to VIII indicative of a spermiation defect (S16r; Fig. 7E). In
agreement with these observations, the caudal epididymides of
TIF1βSc−/− mutants contained only few spermatozoa (Z, compare
Fig. 7C and F). Old TIF1βSc−/− mutants displayed, in addition to a
failure of spermatid release, a testicular degeneration manifested by
(i) a marked reduction in the diameters of the seminiferous tubules
(T, compare Fig. 7G and J), (ii) frequent desquamation of immature
germ cells (i.e., round spermatids; not shown), (ii) the presence of
vacuoles in the seminiferous epithelium (arrowhead in Fig. 7K), and
(iii) the existence of seminiferous tubules markedly depleted in germ
cells or lined only by SC (Fig. 7K and data not shown). In contrast to
TIF1βSc−/−mutants, the testes from TIF1βScHP1box/−mutants analyzed
by histology at W7 (n = 4) and M12 (n = 4) were indistinguishable
from those of age-matched TIF1βSc+/− control mice (Fig. 7M and N),
and accordingly their caudal epididymides contained abundant
spermatozoa stores (Fig. 7O).
Fig. 4. TIF1β undergoes sub-nuclear redistribution during early post-gastrulation development in a HP1-binding domain-dependent manner. (A–D) Confocal microscopic analysis of
TIF1β expression (red signals) in WT embryos at E7.0 (A and B) and E8.5 (C and D). Note that (B) and (D) represent high magniﬁcations of the boxes in (A) and (C) respectively and
that the DAPI counterstaining (blue signal) of the immunostained sections, highlights A/T-rich repeat sequences present in the centromeric heterochromatin (bright blue patches).
(E–H) Comparative confocal microscopic analysis of the sub-nuclear localization of TIF1β in the ectoderm of E8.5 WT (E and F) and TIF1βHP1box mutant (G and H) littermates.
Abbreviations: ex, extraembryonic tissue; ee, embryonic ectoderm. Scale bar: 200 μm (A–C), 30 μm (B–D), 15 μm (E–H).
553M. Herzog et al. / Developmental Biology 350 (2011) 548–558The number of SC in adult testis determines its size, as each SC has
the capacity to support survival and differentiation of only a limited
number of germ cells (Sharpe et al., 2003). Therefore, both the reduction
in testis size and the germ cell depletion observed in TIF1βSc−/− mutant
mice could be accounted for by a reduced number of SC. As only
immature SC proliferate, the total number of SC populating the adult
testis is established before sexual maturity, around 3 weeks after birth
(Vergouwen et al., 1993). Using 5-bromodeoxyuridine (BrdU) incorpo-
ration, we determined the rate of SC proliferation in testes at 5 day
postpartum (P5), a stage when SC divide very actively. No signiﬁcant
differences in the percentage of BrdU-positive SC were observed
between WT (24.5±2.3%; n=4) and TIF1βSc−/− testes (28.9±2.4%;
n=4). Furthermore, the ratio of Sertoli cells to spermatogonia in
TIF1βSc−/− mutants and WT testes, 4.7±0.7 and 6±1.2, respectively,
was not statistically different (Fig. S7B). These results indicate that theabsence of TIF1β in SC does neither alter SC nor spermatogonia
proliferation (Fig. S7).
Altogether these results indicate that TIF1β is not required for SC
morphological differentiation but plays an essential role in their
spermatogenetic functions. Indeed TIF1b is determinant within SC for
spermiation and for the maintenance of the seminiferous epithelium.
We further demonstrate that the integrity of the HP1box or TIF1β
association to heterochromatin is required for TIF1β SC-speciﬁc
functions.
Discussion
In this study we demonstrate unambiguously that in vivo TIF1β
acts through different mechanisms: one that is critically dependent
upon its interaction with HP1 while others are not.
Fig. 5. The expression and localization of HP1α is not affected by TIF1β HP1box
mutation. Confocal microscopic analysis of HP1α (red signals) and of DAPI counter-
staining (blue signal) in E8.5 WT and TIF1βHP1box embryos. Scale bar: 15 μm.
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We show that TIF1β HP1box mutation in mice leads to early
developmental arrest shortly after gastrulation. Considering the recent
literature and our own unpublished data, TIF1β binds to more than 3000
sites within mouse chromatin (O'Geen et al., 2007; Hu et al., 2009 and
data not shown). Thus, it is likely that the inability of TIF1βHP1box
embryos to develop beyond E8.5 results from multifactorial effects. We
have nevertheless identiﬁed molecular and cellular defects that may, in
part, explain this lethality. Firstly, we found that Nanog and Oct4
expression is decreased in E6.5 TIF1βHP1box embryos, as compared to
theirWT littermates. Both genes have been shown to play crucial roles in
the maintenance of the pluripotent status of ES cells (reviewed by
Chambers and Tomlinson, 2009). Furthermore, Nanog inactivation in the
mouse leads to a developmental arrest prior to gastrulation, suggesting
that its decreased expression in TIF1βHP1box mutant embryos could be
responsible for their developmental arrest (Mitsui et al., 2003).
Intriguingly, TIF1β has been reported to directly bind to both NANOG
itself and to the regulatory sequence within the Nanog gene (Wang et al.,
2006; Loh et al., 2007; Hu et al., 2009). Our ﬁnding that the disruption
the TIF1β HP1box results in decreased Nanog expression suggests that
the TIF1β/HP1 complex could positively regulate Nanog expression. The
possibility that of a molecular complex with known functions in
transcriptional repression could also be involved in transcriptional
activation is not unprecedented, as the Sin3A/HDAC corepressor complex
also plays a direct positive role in the regulation of Nanog expression
through interaction with the transcription factor Sox2 (Baltus et al.,
2009). Secondly, we ﬁnd that the number of mitotic cells is signiﬁcantly
increased in themutant embryos as compared toWT, suggesting a defect
in chromosome segregation. Interestingly, we found that the mitotic
checkpoint PTTG1 is more abundant in E7.5 TIF1βHP1box embryos than in
WT littermates. PTTG1 is involved in the regulation of sister chromatid
separation during the mitotic phase of the cell cycle (reviewed by
Cohen-Fix, 2001) and accumulation of PTTG1 protein has been shown to
disrupt mitotic progression and to inhibit growth in cultured cells (Ying
et al., 2006; Mu et al., 2003). It is therefore possible that the altered
progression of TIF1βHP1box mutant cells through mitosis is a directconsequence of increased expression of PTTG1 and could be involved in
TIF1βHP1box mutant embryos developmental arrest. Furthermore, Swi6
the yeast ortholog of HP1 itself is known to be involved in chromosome
segregation in yeast by being involved in sister chromatid cohesion
(Ekwall et al., 1995; Bernard et al., 2001). Finally, we found that the p21
is up-regulated in TIF1βHP1box as compared to WT embryos. This result is
consistent with the report that p21 is a direct target of TIF1β through
binding of the KRAB-ZFP protein ZBRK1 within the p21 promoter region
(Lee et al., 2007). P21 is well known to be involved in the regulation of
cell cycle progression and in differentiation, suggesting that its increased
expression could participate to TIF1βHP1box embryos phenotype.
Some TIF1β functions are independent of its interaction with HP1
Up to now, all TIF1β functions as transcriptional corepressor were
shown to require interaction between TIF1β and HP1, but whether the
disruption of this interaction leads to complete or strong but partial loss of
TIF1β repression activity, is a matter of debate (Ayyanathan et al., 2003;
Wolf et al., 2008; Riclet et al., 2009). In the case of a partial loss, TIF1β
target genes would still be repressed by a mutated TIF1β lacking the
HP1box, albeit less efﬁciently thanbyTIF1β, resulting inmilderphenotype
than those observed upon complete inactivation of TIF1β. Another, non-
mutually exclusive possibility would be that some of TIF1β functions
could be completely independent of its interaction with HP1. Several
studies support this latter possibility. For instance, TIF1βwas reported to
function as coactivator of several proteins including the transcription
factors C/EBPβ (Chang et al., 1998) and NGFI-B/Nur77 (Rambaud et al.,
2009), the coactivators TRIP-Br1 (Hsu et al., 2001), STAT3 (Tsuruma et al.,
2008) and Oct4 (Seki et al., 2010). TIF1βwas also shown tomodulate the
activity of p53 and E2F1 through involvement in their post-translational
modiﬁcations (Wang et al., 2005, 2007; Tian et al., 2009). These functions
are unlikely to require the interaction between TIF1β and HP1 and could
account for the phenotypic differences resulting from TIF1β inactivation
and TIF1β HP1box mutation. Furthermore, a detailed genome-wide
approach comparing TIF1β binding sites to sites enriched in the H3K9 tri-
methylated mark well known to be recognized by HP1 showed only 25%
overlap, strongly suggesting that HP1 is not present on the remaining 75%
TIF1βbinding sites, and therefore that TIF1β-mediated regulationofmany
genes could be independent of its interaction with HP1 (O'Geen et al.,
2007).
TIF1β targeting to, but not maintenance within heterochromatin is essential
for TIF1β functions
We show here that TIF1β associates with heterochromatin of E8.5
embryonic cells as well as with that of SC, and that this association
requires the TIF1β HP1box. As this relocation occurs at a developmental
stage when TIF1βHP1box embryos start to be growth-retarded it is very
likely to be physiologically relevant. Interestingly, in these two in vivo
models, disruption of the interaction between TIF1β and HP1 occurs at
different stepswith respect to TIF1β associationwith heterochromatin. In
the caseof theTIF1βHP1boxgerm-linemutation, the interactionbetween
TIF1β andHP1 is already impaired prior to the timewhen TIF1β becomes
normally associated with heterochromatin. In contrast, in the case of the
SC-speciﬁc TIF1βHP1boxmutation, interaction between TIF1β andHP1 is
only impaired at a time when TIF1β is already associated with
heterochromatin (data not shown). Thus, the effect of the TIF1β HP1box
mutation is detrimental to TIF1β functions when the interaction between
TIF1β and HP1 is disrupted prior to normal targeting of TIF1β to
heterochromatin, as here during embryonic development and as
previously reported for early differentiating F9 cells (Cammas et al.,
2004). On the other hand, when the TIF1β HP1box mutation is induced
after the normal time of TIF1β association with heterochromatin, as here
in SC and as previously shown for retinoic acid-induced primitive
endodermal cells (Cammas et al., 2004), the mutation leads to TIF1β
dissociation fromheterochromatin but has no effect on TIF1β functions. It
Fig. 6.Mutation of TIF1β HP1box prevents its association with pericentromeric heterochromatin in SC of post-pubertal testes. Frozen histological sections were incubated with the
anti-TIF1β antibody and revealed with a Cy3-conjugated secondary antibody (red signal) and nuclei were counterstained with DAPI (blue signal). (B, E, H, and K) Cy3 and (A, D, G,
and J) DAPI labeling. (C, F, I, and L) Superimposition of the two ﬂuorochromes. (A–L) Confocal images of single optical sections through the SC nucleus of wild-type (A–C), TIF1βSc−/−
(D–F), TIF1βSc+/− (G–I), and TIF1βScHP1box/− (J–L) testes. In WT and TIF1βSc+/− SC, TIF1β is preferentially associated with the pericentromeric heterochromatin organized in
chromocenters (arrowheads). No immunostaining for TIF1β is detected in TIF1βSc−/− mutant SC. In TIF1βScHP1box/− mutant SC, TIF1β is diffusely distributed throughout the
nucleoplasm, but excluded from the pericentromeric heterochromatin (arrows). Scale bar, 2 μm.
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differentiating cells is instrumental to TIF1β functions, whereas the
maintenance of this heterochromatic localization is dispensable. The
function of the association of TIF1β to heterochromatin remains to be
elucidated. However one can postulate that it could be important for
tethering of TIF1β target genes to heterochromatin for stable silencing.
This possibility is supported by our previous observation that in F9 cells,
the association between TIF1β and HP1 facilitates the recruitment of the
TIF1β target geneMEST to pericentromeric heterochromatin (Riclet et al.,
2009). It is also possible that the TIF1β–HP1 complex participates to the
formation of a chromatin structure only required at a speciﬁc stage of the
differentiation process. Other examples of such differentiation stage
speciﬁc regulation have been shown. Indeed, DNAmethylation of speciﬁc
genes, such as pluripotency and germ-line speciﬁc genes, occurs mainly
during loss of pluripotency that accompanies the change from ES cells to
progenitor cells. In contrast, there is almost no difference of DNAmethylation between progenitor cells and terminally differentiated cells
(Mohn et al., 2008). We have previously shown that TIF1β–HP1
association is involved in DNA methylation of MEST, a TIF1β target gene
(Riclet et al., 2009). It is therefore conceivable that TIF1β–HP1 is
speciﬁcally involved in TIF1β target genes regulated by DNAmethylation
in vivo and that this function is only required for a limitedwindowof time
during cell differentiation.
Materials and methods
ES cell selection
ES cells were electroporated with pTIF1βLHL:HP1box containing the
PxAxA mutation in the HP1box domain of TIF1β (Cammas et al., 2004).
Hygromycin resistant clones with homologous recombination of a single
copy of the targeting vector as assessed by Southern blot with two
Fig. 7. Spermatogenesis and spermiation are impaired in TIF1βSc−/−, but not in TIF1βScHP1box/−mutant mice. (A–O) Representative histological sections of testes (A, B, D, E, G, H, J, K,
M, and N) and epididymides (C, F, I, L, and O) at W7 and M12 stained with hematoxylin and eosin (C, F, G, I, J, L, M, and O) or with periodic acid-Schiff (A, B, D, E, H, K, and N).
Genotypes as indicated. Note that the sections displayed on a given line were obtained from the same mouse. L, leptotene spermatocytes; P and PR, pachytene and preleptotene
spermatocytes, respectively; S7, S9, and S16, spermatids at steps 7, 9, and 16 of their maturation, respectively; S16r, retained step 16 spermatids; T, seminiferous tubule lumens; Z,
spermatozoa. Arrowheads point to vacuoles in the seminiferous epithelium. Roman numerals designate stages of the seminiferous epithelium cycle. Scale bar (in O): 20 μm (A, B, D,
E, H, K, and N) and 50 μm (C, F, G, I, J, L, M, and O). See also Figs. S2 and S3.
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These clones were further analyzed for the incorporation of the HP1box
mutation by PCR with primers ﬂanking the HP1box motif: VR216 andTV211, followed by digestion with Eco47III, (Cammas et al., 2004) and
called TIF1βL2HP1box/+. The karyotype of these ES cells was veriﬁed by
metaphase spreading.
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TIF1βL2HP1box/+ ES cells were used to derive TIF1βHP1box/+ mice that
were then intercrossed. Genotypes of the offspring were determined by
PCR on genomic DNA extracted from tails (newborn, adult mice), from
yolk sac (E8.5 to E12.5) or fromparafﬁn-embedded sectionswith primers
surrounding the site of insertion of the LoxP site (YD208, VR211; Cammas
et al., 2000, 2004) or by PCR on cDNA detecting the HP1box mutation as
described above. To generate SC-speciﬁc TIF1β knock-out mice, mice
carrying loxP-ﬂanked (ﬂoxed) alleles of TIF1β (TIF1βL2/L2; Cammas et al.,
2000)were crossedwithmice bearing theAmh-cre transgene (Lécureuil
et al., 2002) to generate TIF1βL2/+:Amh-Cretg/0 mice. These mice were
then crossed with TIF1βL2/L2 mice to generate TIF1βL2/L2:Amh-Cretg/0
males; these mice were referred to as TIF1βSc−/− null mutants. These
crosses also generated TIF1βL2/L2:Amh-Cre0/0 control males, which did
not display histological defects and were thus referred to as wild-type
(WT) mice. To generate SC-speciﬁc knock-in mice expressing only the
mutant TIF1βHP1box protein, TIF1βHP1box/+ and Amh-Cretg/0 were ﬁrst
intercrossed to produce TIF1βHP1box/+:Amh-Cretg/0 males. These mice
were then crossed with TIF1βL2/L2 mice to generate TIF1βHP1box/L2:Amh-
Cretg/0 males; these mice were referred to as TIF1βScHP1box/− knock-in
mutants. These crosses also generated TIF1βHP1box/L2:Amh-Cre0/0 and
TIF1βL2/+:Amh-Cretg/0 control males, which did not display histological
defects. Genotypes were determined by genomic PCR onDNA extracted
from tails using amixture of three primers TV210, VR211 and YD208 for
the wild-type, deleted, ﬂoxed and knock-in TIF1β alleles as previously
described (Cammas et al., 2000, 2004) and a mixture of two primers
TK139 (5 ′-ATTGCCTGCATTACCGGTC-3 ′) and TK141 (5 ′-
ATCAACGTTTTGTTTTCGGA-3′) for the Amh-Cre transgene. All animal
procedures were approved by the French Ministry of Agriculture
(agreement B67-218-5) according to guidelines that are in compliance
with the European legislation on care and use of laboratory animal.
Immunoﬂuorescence and confocal microscopy analyses
Immunohistochemical detection of TIF1β was performed on 8 μm
thick cryosections hydrated in phosphate-buffered saline (PBS), and then
post-ﬁxed in 4% paraformaldehyde (PFA) in PBS for 10 min at 4 °C.
Sectionswere rinsed in PBS containing 0.1% TritonX-100 (PBST; 3×5min
at room temperature), saturated with 5% normal horse serum in PBST for
30 min at room temperature, and incubated with the anti-TIF1β
polyclonal antibody (PF64; 4 μg/ml, Cammas et al., 2002) overnight at
4 °C. Sectionswerewashed in PBST (3×5min), incubated for 1 h at room
temperature with the secondary antibody (Cy3-conjugated anti-rabbit
IgG; diluted 1:400 in PBS, Jackson Laboratories), washed in PBST (3×5
min) andmounted in Vectashield® (Vector) containing DAPI at 10 μg/ml.
Image acquisition was performed using a Leica TCS-4D confocal scanning
microscope (Leica Microsystems, Heidelberg, Germany).
Histological analysis and detection of apoptotic cells
For histological analysis, embryos or testes were ﬁxed in Bouin's
ﬂuid for 48 h, embedded in parafﬁn, sectioned at a thickness of 5 μm,
and stained with either hematoxylin and eosin or periodic acid-Schiff.
For detection of apoptotic cells, testes were perfusion-ﬁxed with 4%
PFA in PBS, whereas embryos were ﬁxed within their decidua Testes
and decidua were then maintained in this ﬁxative for 16 h at 4 °C, and
embedded in parafﬁn. TUNEL assay was performed on histological
sections of three mutant and WT littermates using the ApopTag®
Fluorescein Direct In Situ Apoptosis Detection kit according to the
manufacturer's instructions (MP Biomedicals). Total cell numbers
were determined by DAPI staining. The mean proportion (± SD) of
TUNEL-positive cells was determined from 8 to 13 sections per
embryo representing the whole embryo. Statistical analysis was
carried out using Student's t tests.BrdU incorporation and immunodetection of phosphorylated histone H3
To detect cells in S-phase, 5-bromo-2′-deoxyuridine (BrdU; Sigma)
(100 mg/kg of body weight) was injected i.p. in pregnant TIF1βHP1box/+
females or inmales.Micewere sacriﬁced 2 h later; embryos or testiswere
collected and ﬁxed in 4% paraformaldehyde (PFA) at 4 °C for 12 h,
embedded in parafﬁn and processed for immunohistochemistry. The
sections were incubated with an anti-BrdU antibody [Sigma; diluted
1:500 in PBS containing 0.05% Tween (PBST)] for 16 h at 4 °C, revealed
with Cy3-conjugated goat anti-mouse IgG diluted 1:400 in PBST for 1 h at
room temperature, and mounted in Vectashield® containing DAPI.
Detection of mitotic cells was carried out using an anti-phosphorylated
histone H3 (Ser10) antibody (Chemicon) diluted 1:1000 in PBST for 16
h at 4 °C. Statistical analysis was carried out using Student's t tests.
RT-PCR analysis
RNA extraction on single embryo was performed with a Trizol®
(Invitrogen) solution according to the manufacturer's protocol. RNA was
redissolved in 12 μl RNAse-free water. Reverse transcription (RT) was
performed according to the manufacturer's speciﬁcation (Superscript II
RT; Invitrogen) adapted to minute amounts using an oligo(dT)15 and a
mixture of two enzymes: Superscript II (Invitrogen) andAMV-RT (Roche)
(1:1). PCR were performed in a LightCyclerTM (Roche). The PCR primers
used for ampliﬁcation are available upon request. All quantiﬁcationswere
normalized to endogenous control HPRT.
Fertility assays
Seven-week-old TIF1βSer−/− and control males were bred with
fertile WT C57BL/6 females for up to 5 months. The number of litters
produced and pups per litter were counted for each female.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ydbio.2010.12.014.
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